Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 15,180 | 7,456 | 1,406 | 899 | 3,088 |
| Cost of Goods | 8,397 | 3,711 | N/A | N/A | N/A |
| Gross Profit | 6,783 | 3,745 | 1,406 | 899 | 3,088 |
| Operating Expenses | 44,030 | 53,212 | 16,914 | 19,694 | 21,953 |
| Operating Income | -36,850 | -48,756 | -15,508 | -18,795 | -18,865 |
| Interest Expense | 452 | 156 | 0 | 0 | 0 |
| Other Income | 248 | 1,411 | 435 | 960 | 768 |
| Pre-tax Income | -37,054 | -47,501 | -15,073 | -17,835 | -18,097 |
| Income Tax | -529 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -36,525 | -47,501 | -15,073 | -17,835 | -18,097 |
| Net Income | $-36,525 | $-47,501 | $-15,073 | $-17,835 | $-18,097 |
| EPS Basic Total Ops | -27.59 | -50.08 | -27.14 | -32.23 | -43.93 |
| EPS Basic Continuous Ops | -27.62 | -50.09 | -27.20 | -32.30 | -43.91 |
| EPS Diluted Total Ops | -27.59 | -50.08 | -27.14 | -32.23 | -43.93 |
| EPS Diluted Continuous Ops | -27.62 | -50.09 | -27.20 | -32.30 | -43.91 |
| EBITDA(a) | $-33,318 | $-46,219 | $-14,681 | $-17,909 | $-17,273 |